Our Pricing

Mounjaro vs Ozempic UK: Which Weight Loss Treatment Is Right for You?

Searching for mounjaro vs ozempic uk comparisons? Both medications are now available at Cured Pharmacy, with transparent pricing from £135.00 and free clinical consultations by UK-registered prescribers. Understanding the key differences between tirzepatide and semaglutide can help you make an informed choice about which treatment may be more suitable for your weight loss journey.

Understanding Mounjaro vs Ozempic: The Key Differences

Mounjaro (tirzepatide) and Ozempic (semaglutide) both belong to the GLP-1 receptor agonist class, but they work through fundamentally different mechanisms. Mounjaro is the first dual GIP/GLP-1 receptor agonist licensed by the MHRA, meaning it activates two separate hormone pathways that regulate appetite and blood sugar control [1]. Ozempic, by contrast, activates only the GLP-1 pathway, making it a single-receptor agonist.

This dual-action mechanism in Mounjaro has translated to superior weight loss outcomes in head-to-head clinical trials. The SURPASS-2 study directly compared tirzepatide against semaglutide 1mg and found that patients on the highest tirzepatide dose (15mg) achieved an average 12.4kg greater weight reduction over 40 weeks compared to semaglutide [1]. Both medications require once-weekly subcutaneous injection and are prescription-only treatments in the UK, requiring clinical assessment by a registered prescriber before dispensing.

Clinical Efficacy: Mounjaro vs Ozempic Weight Loss Results

In the landmark SURMOUNT-1 trial, participants taking Mounjaro 15mg achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% in the placebo group [2]. Nearly 40% of participants achieved weight loss exceeding 25% of their starting body weight, a threshold rarely seen with pharmacological interventions.

Ozempic, whilst highly effective in its own right, demonstrated lower average weight loss in the STEP trials when used at the 1mg dose licensed for type 2 diabetes. The STEP 1 trial using semaglutide 2.4mg (marketed as Wegovy rather than Ozempic for weight management) showed average weight reduction of 14.9% over 68 weeks [3]. It's worth noting that Ozempic is primarily licensed in the UK for type 2 diabetes management, whereas Mounjaro has specific licensing for chronic weight management in adults with a BMI ≥30 kg/m² or ≥27 kg/m² with weight-related comorbidities.

Real-World Weight Loss Expectations

Clinical trial results represent controlled conditions, and individual responses vary considerably based on adherence, lifestyle modifications, and metabolic factors. Your UK prescriber will assess your medical history, current medications, and weight loss goals to determine which treatment may offer the most appropriate risk-benefit profile for your circumstances. Both medications work most effectively when combined with a reduced-calorie diet and increased physical activity, as recommended by NICE guidelines for obesity management [4].

Dosing Schedules and Administration

Mounjaro follows a structured dose escalation protocol, starting at 2.5mg weekly for four weeks, then increasing to 5mg for four weeks. Depending on tolerability and clinical response, your prescriber may increase the dose further to 7.5mg, 10mg, 12.5mg, or the maximum 15mg weekly. This gradual titration helps minimise gastrointestinal side effects that commonly occur when starting GLP-1 medications.

Ozempic similarly uses dose escalation, beginning at 0.25mg weekly for four weeks, then 0.5mg weekly. The dose may be increased to 1mg weekly if additional glycaemic control is needed for diabetes management. For weight loss purposes, higher doses of semaglutide are typically prescribed under the Wegovy brand rather than Ozempic. Both medications use pre-filled injection pens designed for subcutaneous administration in the abdomen, thigh, or upper arm.

Injection Technique and Storage

Both Mounjaro and Ozempic pens should be stored in the refrigerator between 2°C and 8°C before first use. Once in use, pens may be kept at room temperature (not exceeding 30°C) for up to 21 days. Your pharmacist will provide detailed administration instructions, but the injection process is straightforward: attach a new needle, dial your prescribed dose, inject into clean skin, and hold for 5-10 seconds before withdrawing. Rotating injection sites helps prevent lipohypertrophy and ensures consistent absorption.

Side Effects: What to Expect with Mounjaro vs Ozempic

Both medications share a similar side effect profile, with gastrointestinal symptoms being the most commonly reported. In clinical trials, nausea occurred in approximately 25-30% of Mounjaro users and 20-24% of Ozempic users during dose escalation phases [1][3]. Other frequent gastrointestinal effects include diarrhoea, constipation, abdominal discomfort, and reduced appetite—which, whilst contributing to weight loss, can be unpleasant for some patients.

More serious but rare adverse events include pancreatitis, gallbladder disease, and hypoglycaemia (particularly when used alongside other glucose-lowering medications). Both medications carry a boxed warning in some jurisdictions regarding thyroid C-cell tumours observed in rodent studies, though no causal relationship has been established in humans. Neither medication should be used in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 [2][3].

Most gastrointestinal side effects diminish over 4-8 weeks as your body adapts to the medication. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms. If side effects become severe or persistent, your prescriber may adjust your dose or recommend an alternative treatment approach.

Cost Comparison: Mounjaro vs Ozempic UK Pricing

At Cured Pharmacy, Mounjaro is available from £135.00 per month, with transparent pricing displayed before you complete your free clinical consultation. Pricing varies depending on your prescribed dose, as higher-strength pens contain more medication. All prices include the cost of your UK prescriber assessment, dispensing by our GPhC-registered pharmacy team, and discreet home delivery.

Ozempic pricing in the UK varies by supplier and dose strength, but it's important to note that Ozempic is primarily licensed for type 2 diabetes rather than weight management. For dedicated weight loss treatment with semaglutide, Wegovy is the appropriately licensed option and is available at Cured Pharmacy with competitive pricing. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), ensures all weight loss medications are dispensed only after thorough clinical assessment to confirm suitability and safety.

Unlike some online providers, Cured Pharmacy displays prices upfront—before you begin your consultation—so there are no unexpected costs. We guarantee the lowest prices in the UK for genuine, MHRA-licensed medications, and all treatments are sourced through legitimate UK pharmaceutical supply chains.

What's Included in Your Treatment Cost

Your treatment price includes a comprehensive online consultation reviewed by a UK-registered prescriber (typically completed in under three minutes), dispensing by our GPhC-registered pharmacy team, and delivery in 100% discreet packaging. Follow-up consultations for dose adjustments or prescription renewals are included at no additional charge. We never apply hidden fees or mandatory subscription models—you maintain full control over your treatment timeline.

Getting Started: How to Access Mounjaro vs Ozempic Through Cured Pharmacy

Both Mounjaro and Ozempic are prescription-only medications in the UK, meaning you'll need clinical approval from a registered prescriber before we can dispense your treatment. At Cured Pharmacy, this process is streamlined through our free online consultation platform, which takes under three minutes to complete. You'll answer questions about your medical history, current medications, weight loss goals, and any relevant health conditions.

A UK-registered prescriber will review your consultation within hours (often much faster) and determine whether Mounjaro, Ozempic, Wegovy, or an alternative weight loss treatment is appropriate for your circumstances. If approved, your prescription is sent directly to our pharmacy team, and your medication is dispatched for next-day delivery in discreet, unmarked packaging. If the prescriber determines that GLP-1 medications aren't suitable for you, they'll explain why and may suggest alternative approaches.

You can start your free consultation now by visiting our weight loss assessment page. Our clinical team is available by phone on (+44) 116 4646009 if you have questions before beginning your consultation. All patient data is handled in strict accordance with UK GDPR regulations and NHS data security standards.

Ongoing Support and Monitoring

Weight loss treatment with GLP-1 medications requires ongoing monitoring to assess efficacy, manage side effects, and adjust dosing as needed. Cured Pharmacy provides continuous access to our clinical team for prescription renewals, dose escalations, and any concerns that arise during treatment. Your prescriber will typically recommend follow-up assessments every 4-12 weeks, depending on your response to treatment and overall health status. This collaborative approach ensures you receive safe, effective, and personalised care throughout your weight loss journey.

Scientific References

1. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
3. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
4. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. https://www.nice.org.uk/guidance/cg189

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, dietary modifications, and lifestyle changes. Mounjaro and Ozempic are registered trademarks of their respective manufacturers.